no limitation
Conditions
Interventions
Individualized interactive play (20 minutes) for children using Aibo twice a week for a minimum of 4 weeks starting after obtaining consent during the hospitalization period.
Sponsors
National Center for Child Health and Development
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Children who have been hospitalized at the center for at least one month and whose parents were able to obtain research consent
Exclusion criteria
Exclusion criteria: Patients who are 18 years of age or older at the time consent is obtained, other patients who are deemed inappropriate as subjects by the principal investigator, and patients who are discharged from the hospital within one month of the start of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood (serotonin, noradrenaline, cortisol, chromogranin A, secreted immunoglobulin levels (s-IgA), interleukin, TNF, HVA, MHPG measurements, oxytocin equivalent) At session initial intervention, after 1 week of intervention, after 4 weeks of intervention, after 6 weeks of intervention, after 8 weeks of intervention, after 10 weeks of intervention, and after 12 weeks of intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| STAI, VAS, Japanese version of DSRS-C, infant version of QOL scale (for parents), elementary and middle school QOL scale (for parents), CBCL FDT, SUBI, length of hospitalization, complications, etc. Children: number of utterances and emotional expressions (positive and negative in two directions), etc., eye contact, voice, touching, emotional parameters of aibo, etc., by participant observation | — |
Countries
Japan
Contacts
Public ContactKyoko Tanaka
National Center for Child Health and Development Division of Mental Health Care, Department of Child and Adolescent Liaison
Outcome results
None listed